Schedule 1
Class A controlled drugs

s 2(1)

1 The following substances, namely:
  • Acetorphine (03-acetyl-7,8-dihydro-7 α-[1 (R)-hydroxy-1-methylbutyl]-06-methyl-6,14-endoethenomorphine)

    Bufotenine (3-(2-dimethylaminoethyl)-5-hydroxyindole)

    Cantharidin (hexahydro-3a,7a-dimethyl-4,7-epoxyisobenzofuran-1,3-dione)

    Cocaine (methyl ester of benzoylecgonine), except when contained in a Class C controlled drug

    Desomorphine (dihydrodeoxymorphine)

    DET (N,N-diethyltryptamine)

    DMA (2-amino-1-(2,5-dimethoxyphenyl)propane)

    DMHP (3-(1,2-dimethylheptyl)-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran)

    DMT (N,N-dimethyltryptamine)

    DOB (2-amino-1-(4-bromo-2,5-dimethoxyphenyl)propane) (also known as bromo-DMA)

    Etorphine (7,8-dihydro-7 α-[1 (R)-hydroxy-1-methylbutyl]-06-methyl-6,14-endoethenomorphine)

    Heroin (diacetylmorphine)

    Ketobemidone (4-meta-hydroxyphenyl-1-methyl-4-propionylpiperidine)

    Lysergic acid (essential precursor for manufacture of LSD)

    Lysergide (N,N-diethyllysergamide or lysergic acid diethylamide)

    MDA (2-amino-1-(3,4-methylenedioxyphenyl) propane)

    Mescaline (3,4,5-trimethoxyphenethylamine)

    Methamphetamine (2-methylamino-1-phenylpropane)

    5-methoxydimethyltryptamine (5-methoxy-N,N-dimethyltryptamine)

    2-methoxy-4,5-methylenedioxyamphetamine (2-amino-1-(2-methoxy-4,5-methylenedioxyphenyl) propane) (also known as MMDA or MMDA-2)

    3-methoxy-4,5-methylenedioxyamphetamine (2-amino-1-(3-methoxy-4,5-methylenedioxyphenyl) propane) (also known as MMDA)

    MPTP (1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine)

    Parahexyl (3-hexyl-1-hydroxy-7,8,9,10-tetrahydro-6,6,9-trimethyl-6H-dibenzo [b,d] pyran)

    PCE (N-ethyl-1-phenylcyclohexylamine)

    PCPY (1-(1-phenylcyclohexyl)pyrrolidine)

    PEPTP (1-(2-phenylethyl)-4-phenyl-1,2,5,6-tetrahydropyridine)

    Phencyclidine (1-(1-phenylcyclohexyl) piperidine)

    PHP (1-(1-phenylcyclohexyl)pyrrolidine)

    Piperidyl benzilates (N-methylpiperidyl benzilates and N-ethylpiperidyl benzilates but excluding the methobromide salts)

    PMA (2-amino-1-(4-methoxyphenyl)propane)

    Psilocine (3-(2-dimethylaminoethyl)-4-hydroxyindole)

    Psilotsin (3-(2-dimethylaminoethyl)-4-hydroxyindole)

    Psilocybine (3-(2-dimethylaminoethyl) indol-4-yl dihydrogen phosphate)

    STP,DOM (2-amino-1-(2,5-dimethoxy-4-methyl) phenylpropane)

    TCP (1-[1-(2-thienyl)cyclohexyl]piperidine)

    TMA (2-amino-1-(3,4,5-trimethoxyphenyl)propane).

    Schedule 1 clause 1 4-bromo-2,5-dimethoxyamphetamine: repealed, on 2 September 1996, by section 6(1)(a) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 Cocaine: inserted, on 13 January 1988, by section 8 of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

    Schedule 1 clause 1 2,5-dimethoxyamphetamine: repealed, on 2 September 1996, by section 6(1)(b) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 DMA: inserted, on 2 September 1996, by section 6(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 DOB: inserted, on 2 September 1996, by section 6(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 Lysergic acid: inserted, on 2 September 1996, by section 6(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 Methamphetamine: inserted, on 30 May 2003, by clause 4 of the Misuse of Drugs (Changes to Controlled Drugs) Order 2003 (SR 2003/47).

    Schedule 1 clause 1 4-methoxyamphetamine: repealed, on 2 September 1996, by section 6(1)(c) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 2-methoxy-4,5-methylenedioxyamphetamine: inserted, on 2 September 1996, by section 6(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 3-methoxy-4,5-methylenedioxyamphetamine: replaced, on 2 September 1996, by section 6(2) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 MPTP: inserted, on 13 January 1988, by section 8 of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

    Schedule 1 clause 1 PCE: inserted, on 21 May 1981, by clause 2 of the Misuse of Drugs Order 1981 (SR 1981/114).

    Schedule 1 clause 1 PCPY: inserted, on 21 May 1981, by clause 2 of the Misuse of Drugs Order 1981 (SR 1981/114).

    Schedule 1 clause 1 PEPTP: inserted, on 13 January 1988, by section 8 of the Misuse of Drugs Amendment Act (No 2) 1987 (1987 No 193).

    Schedule 1 clause 1 PHP: inserted, on 21 May 1981, by clause 2 of the Misuse of Drugs Order 1981 (SR 1981/114).

    Schedule 1 clause 1 PMA: inserted, on 2 September 1996, by section 6(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 TCP: inserted, on 21 May 1981, by clause 2 of the Misuse of Drugs Order 1981 (SR 1981/114).

    Schedule 1 clause 1 Tetrahydrocannabinols: repealed, on 2 September 1996, by section 6(1)(d) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 Thalidomide: repealed, on 9 August 2011, by section 7 of the Misuse of Drugs Amendment Act (No 2) 2011 (2011 No 54).

    Schedule 1 clause 1 TMA: inserted, on 2 September 1996, by section 6(3) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

    Schedule 1 clause 1 3,4,5-trimethoxyamphetamine: repealed, on 2 September 1996, by section 6(1)(e) of the Misuse of Drugs Amendment Act 1996 (1996 No 133).

  • 2 The isomers of the substances mentioned in this schedule whenever the existence of such isomers is possible within the specific chemical designation.

  • 3 The esters and ethers of the substances mentioned in this schedule and the esters and ethers of the isomers mentioned in clause 2 whenever the existence of such esters or ethers is possible.

  • 4 The salts of the substances mentioned in this schedule and the salts of the isomers, esters, and ethers mentioned in clause 2 or clause 3.

  • 5 Substances containing any proportion of a substance mentioned in clause 1, clause 2, clause 3, or clause 4.